10x Genomics, Inc.
TXG
$20.92
$0.422.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -9.15% | 11.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.15% | 11.43% | |||
| Cost of Revenue | -15.54% | 8.60% | |||
| Gross Profit | -6.16% | 12.80% | |||
| SG&A Expenses | -9.09% | -2.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.59% | 0.62% | |||
| Operating Income | -8.98% | 50.41% | |||
| Income Before Tax | 15.44% | 46.13% | |||
| Income Tax Expenses | -41.17% | 244.47% | |||
| Earnings from Continuing Operations | 17.12% | 40.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.12% | 40.84% | |||
| EBIT | -8.98% | 50.41% | |||
| EBITDA | -27.13% | 73.75% | |||
| EPS Basic | 17.90% | 41.57% | |||
| Normalized Basic EPS | -3.11% | 53.61% | |||
| EPS Diluted | 17.90% | 41.57% | |||
| Normalized Diluted EPS | -3.11% | 53.61% | |||
| Average Basic Shares Outstanding | 0.95% | 1.26% | |||
| Average Diluted Shares Outstanding | 0.95% | 1.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||